ArticleCancers2022

Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Melanoma Treated with Immunotherapy.

Panagiotis T Diamantopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.